The Advocacy Training Session

 

The first training for certification will include a
variety of topics to give advocates a well-grounded understanding of
methadone treatment, research, regulations and laws that protect
methadone patients and programs.

 

  1. Addiction
    and Methadone
    Tom Payte, MD (Drug Dependence
    Associates) and Joycelyn Woods, MA. (NAMA) The
    biological constructs of addiction will be explained in a way that
    can be understood by lay people (i.e. opiate receptors, Endorphins)
    Methadone dose and what is considered an adequate dose and why it is
    important and what methadone does to make you feel normal.
  2. Regulations
    and Accreditatio
    n
    C. Todd
    Rosendale (CSAT/DPT), Sharon Dow (Joint Commission), Bettye Harrison
    (CARF) and Joanne Page (COA).The new federal regulations will be explained:  What
    they are and how they relate to the state regulations? Accreditation
    and what an accreditation survey is, how it is done, and how
    advocates can be involved.
  3. The
    Different Faces of Advocacy

    Presenters to be announced.
    Advocates from around the country will explain what they do to
    advance the goals of methadone advocacy. This session will also
    explain the different types of advocacy that advocates are involved
    in.
  4. How
    to End Methadone Stigma
    Herman Joseph, Ph.D. The history of
    methadone stigma will be presented and how it has impacted methadone
    treatment and the recipients of it. A plan for advocates to work on
    for ending it will be revealed.
  5. Advocate
    Certification

    Walter Ginter (NAMA Training and Certification Director) What is certification and how it
    will professionalize those committed to methadone advocacy.  The Advocates Code of Ethics, the Goals of Methadone
    Advocacy, and Advocate Certification.

         Top

Similar Posts

  • Letter-1

    Admin 04/09/2021

    Letter to Linda Martz, January 6, 2005 Abusers Are Not Who You Think Linda Martz News-Journal (Mansfield, OH) Tue, 07 Dec 2004 MANSFIELD — Those tracking drug trends “expected” to see a spike in deaths from Methadone within Ohio over the past year, the top official at Ohio’s State Board of Pharmacy says. But the…

  • |

    Federal Agencies

    Admin 10/16/2022

    United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

  • At ATTOD

    Admin 02/19/2022

    Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

  • Myths About Methadone by Emmett Velten

    Admin 01/07/2022

    Education Series Number 3 March 1992 Emmett Velten, Ph.D. is the Clinical Supervisor at the BAART Methadone Program, San Francisco, California. He has worked in methadone treatment as a clinician for over 25 years. Methadone has inspired an immense mythology. Perhaps it is the most extensive mythology surrounding any form of medical or psychological treatment,…